Irnotop 40mg Injection
By Irnotop
Rx
1 Injection in a Vial

Composition
Irinotecan(40mg)

Manufacturer - Metta Life Sciences Private Limited
G-040 Vikas Centre,106, S.V. Road, Santacruz West Mumbai City Mh 400054 India

Expires on or after
July, 2025

liver
It is important to note that there is limited information regarding the use of Irnotop 40mg Injection in individuals with liver disease. Due to this uncertainty, it is highly recommended to seek guidance from your doctor before using this medication to ensure its safety and effectiveness in managing your condition. Consulting with your healthcare provider is crucial in such cases to determine the potential risks and benefits specific to your liver health.

kidney
Irnotop 40mg Injection is generally safe for patients with kidney disease. It is advised to consult a doctor before use. However, it is not recommended for patients undergoing dialysis.

alcohol
It is not known if it is safe to drink alcohol while using Irnotop 40mg Injection. Consult your doctor for advice.

driving
Irnotop 40mg Injection may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Irnotop 40mg Injection is not safe to use during pregnancy because it poses a risk to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor before use.

breastfeeding
Irnotop 40mg Injection is not safe to use while breastfeeding due to potential toxicity to the baby. It is recommended to consult a doctor before using this medication.
Habit Forming | No |
Chemical Class | Camptothecin Derivative |
Therapeutic Class | - |
Action Class | Topoisomerase Inhibitor |
₹900
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024